Abe S, Maruyama I, Arima S, Yamaguchi H, Okino H, Hamasaki S, Yamashita T, Nomoto K, Tahara M, Atsuchi Y
First Department of Internal Medicine, Faculty of Medicine, Kagoshima University, Japan.
Int J Cardiol. 1994 Dec;47(1 Suppl):S7-12. doi: 10.1016/0167-5273(94)90320-4.
To evaluate the activity of platelets and the coagulation/fibrinolytic system 1 month after the onset of acute myocardial infarction, we measured the plasma levels of molecular markers, i.e. beta-thromboglobulin, platelet factor 4, thrombin-antithrombin III complex and D dimer, in 16 patients with acute myocardial infarction and in 11 normal subjects. Blood was drawn through a catheter placed in the pulmonary artery before heparin injection. The heparin-releasable platelet factor 4 was calculated by subtracting the level before the injection of 5000 U of heparin, from the level 5 min after injection. The plasma beta-thromboglobulin, thrombin-antithrombin III complex and the D dimer levels in the acute phase of myocardial infarction were 134.9 +/- 121.2, 11.2 +/- 7.1 and 164.4 +/- 115.3 ng/ml, respectively. These values were significantly higher than those in the normal subjects. The plasma levels of beta-thromboglobulin and thrombin-antithrombin III complex, 1 month after the onset (36.6 +/- 16.4 and 4.6 +/- 2.3 ng/ml, respectively) were not significantly different from those of the normal subjects. In contrast, D dimer and heparin-releasable platelet factor 4 were 216.9 +/- 176.9 and 80.5 +/- 29.3 ng/ml, respectively, and significantly higher than in the normal subjects. These findings suggest a latent but persistent activation of the platelets and the coagulation/fibrinolytic system 1 month after the onset of acute myocardial infarction.
为评估急性心肌梗死发病1个月后血小板及凝血/纤溶系统的活性,我们检测了16例急性心肌梗死患者和11名正常受试者血浆中分子标志物的水平,即β-血小板球蛋白、血小板第4因子、凝血酶-抗凝血酶III复合物及D-二聚体。在注射肝素前,通过置于肺动脉的导管采血。肝素可释放血小板第4因子通过注射5000 U肝素后5分钟时的水平减去注射前的水平来计算。心肌梗死急性期血浆β-血小板球蛋白、凝血酶-抗凝血酶III复合物及D-二聚体水平分别为134.9±121.2、11.2±7.1及164.4±115.3 ng/ml。这些值显著高于正常受试者。发病1个月后血浆β-血小板球蛋白及凝血酶-抗凝血酶III复合物水平(分别为36.6±16.4和4.6±2.3 ng/ml)与正常受试者无显著差异。相比之下,D-二聚体及肝素可释放血小板第4因子分别为216.9±176.9和80.5±29.3 ng/ml,显著高于正常受试者。这些发现提示急性心肌梗死发病1个月后血小板及凝血/纤溶系统存在潜在但持续的激活。